Clinical trial
Botulinum Toxin (BOTOX) for Cerebral Palsy
NCT00060957 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00060957 |
|---|---|
| Title | Botulinum Toxin (BOTOX) for Cerebral Palsy |
| Official title | Botulinum Toxin for Spasticity in Cerebral Palsy |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cerebral Palsy, Muscle Spasticity |
| Intervention type | Drug |
| Interventions | Botulinum toxin type A |
| Enrollment | 40 |
| Start date | Jul 1, 1997 |
| Primary completion | Jun 1, 2002 |
| First posted | May 19, 2003 |
| Last update posted | Sep 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: